One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-137334
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 11 |
Affiliation: Royal Hobart Hospital, Australasian Leukaemia and Lymphoma Group, Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Peter MacCallum Cancer Centre, The Alfred Hospital, Monash University, Australian Centre for HIV and Hepatitis Virology Research, Sir Charles Gairdner Hospital, Westmead Hospital, Gosford Hospital, Royal Adelaide Hospital, University of Technology Sydney, Royal Brisbane and Women's Hospital, University of Sydney, St George Hospital, Concord Repatriation General Hospital, University of Queensland, Princess Alexandra Hospital, Calvary Mater Newcastle Hospital, Queen Elizabeth Hospital, Box Hill Hospital, Canberra Hospital, Olivia Newton-John Cancer Wellness & Research Centre, Austin Health, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Royal Prince Alfred Hospital, Nepean Hospital, Murdoch Children's Research InstituteResults of a Phase 2, Randomized, Double-Blind Study of Sorafenib Versus Placebo in Combination with Intensive Chemotherapy in Previously Untreated Patients with FLT3-ITD Acute Myeloid Leukemia (ALLG AMLM16)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
